LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING

Background: Patients with transfusion-dependent thalassemia (TDT) risk iron overload and require iron chelation therapy. Salvage therapy is warranted for patients demonstrating poor chelation responses. Patients and methods: We retrospectively studied the serum-ferritin (SF) and liver-iron-concen...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jassada Buaboonnam, Chayamon Takpradit, Vip Viprakasit, Nattee Narkbunnam, Nassawee Vathana, Kamon Phuakpet, Kleebsabai Sanpakit, Bunchoo Pongtanakul
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	PAGEPress Publications 2021-10-01
Serie:	Mediterranean Journal of Hematology and Infectious Diseases
Soggetti:	deferasirox Iron chelation Iron Overload Thalassemia
Accesso online:	http://mjhid.org/index.php/mjhid/article/view/4720
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!